Study identifier:NIS-CKR-DUM-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
of PATient education related to CV Risk factOrs in type 2 diabetes mellitus(Patrol).
Low Density Lipoprotein Cholesterol Goal Achievement
-
No
-
All
4045
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|---|
2500 patients Who have records of clinic visit with endocrine internal medicines of nationwide secondary/tertiary hospitals within the last six months. | - |